Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Inventory-to-Revenue : 0.16 (As of Mar. 2024)

---

Jiangsu Wuzhong Pharmaceutical Development Co Inventory-to-Revenue Chart

---

Competitive Comparison of Jiangsu Wuzhong Pharmaceutical Development Co's Inventory-to-Revenue

For the Biotechnology subindustry, Jiangsu Wuzhong Pharmaceutical Development Co's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

---

Jiangsu Wuzhong Pharmaceutical Development Co's Inventory-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jiangsu Wuzhong Pharmaceutical Development Co's Inventory-to-Revenue distribution charts can be found below:

* The bar in red indicates where Jiangsu Wuzhong Pharmaceutical Development Co's Inventory-to-Revenue falls into.

---

Jiangsu Wuzhong Pharmaceutical Development Co Inventory-to-Revenue Calculation

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Jiangsu Wuzhong Pharmaceutical Development Co's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Jiangsu Wuzhong Pharmaceutical Development Co's Inventory-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

---

Jiangsu Wuzhong Pharmaceutical Development Co  (SHSE:600200) Inventory-to-Revenue Explanation

An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:

1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.

Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:

1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.

More Related Terms:

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Jiangsu Wuzhong Pharmaceutical Development Co's Days Inventory for the three months ended in Mar. 2024 is calculated as:

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Jiangsu Wuzhong Pharmaceutical Development Co's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

---

Jiangsu Wuzhong Pharmaceutical Development Co Inventory-to-Revenue Related Terms

Thank you for viewing the detailed overview of Jiangsu Wuzhong Pharmaceutical Development Co's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Total Inventories Revenue Days Inventory Cost of Goods Sold Inventory Turnover

---

Jiangsu Wuzhong Pharmaceutical Development Co (SHSE:600200) Business Description

Executives

Xu Liang Zhi	senior management
Sun Jian Ying	Supervisors
Zhong Yao Wen	Supervisors
Cheng Xi	senior management
Wu Jian Min	Supervisors
Zhao Wei Yi	Director
Jin Li	Director
Sun Tian Jiang	senior management
Zhu Ju Fang	senior management
Yao Jian Lin	Director
Jin Jian Ping	Supervisors
Li Gui Zhi	Supervisors
Luo Qin	Supervisors
Xia Jian Ping	Director
Zhong Shen Zheng	Director